President Yoweri Museveni today launches the first clinical trial of UBV-01N, a natural product anticipated to have antiviral (kill viruses), anti-inflammatory (reduces over reaction of the body to infections) and immunological (directs the immune system in the right direction) ability.
The Presidential Scientific Initiative On Epidemics (PRESIDE) in a Press Statement says the clinical trial wi
Thank You For Reading CEO East Africa Magazine.
Please SUBSCRIBE for UNLIMITED ACCESS to our game-changing stories or LOG IN for existing members.